Skip to content
RecallWatchMedical Device Safety
Class IOngoingZ-2327-2025

Boston Scientific Corporation recalls RELIANCE 4-FRONT

Boston Scientific CorporationSaint Paul, MN, United StatesReported Aug 27, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

RELIANCE 4-FRONT, endocardial cardioversion/defibrillation and pace/sense lead, Permanent Defibrillator Electrodes; Model Nos. 0654, 0655, 0657, 0658, 0682, 0683, 0685, 0686, 0692, 0693, 0695, 0696

Lot / code information

Model
0657
UDI
00802526560934
Model
0682
UDI
00802526560958
Model
0683
UDI
00802526560965
Model
0685
UDI
00802526560972
Model
0686
UDI
00802526560989
Show 8 more code fields
Model
0692
UDI
00802526519017 00802526560996 00802526568664 00802526568688
Model
0693
UDI
00802526518850 00802526519055 00802526537769 00802526561009 00802526568701
Model
0695
UDI
00802526519093 00802526561016
Model
0696
UDI
00802526519987 00802526561207 00802526568831

What the firm is doing

On July 24, 2025, firm notified physicians via Important Medical Device Information letters. The letter provides information on the management of gradually rising daily subthreshold, low-voltage shock impedance (LVSI) pattern associated with calcification of expanded polytetrafluoroethylene (ePTFE) coated single coil (SC) and dual coil (DC) RELIANCE defibrillation leads manufactured by Boston Scientific Corporation between 2002 to 2021. Letter includes recommendations for routine follow-ups of affected leads, and considerations to take if lead replacement is planned. The firm is not recommending any changes to the scheduled follow-up interval for patients with ePTFE lead models.

DistributionShow details

Worldwide Distribution. US nationwide. International distribution worldwide.

Class IWhat this means

A reasonable probability that use of the product will cause serious adverse health consequences or death.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class I recalls

Class IOngoingZ-2879-2026

Boston Scientific Neuromodulation Corporation recalls INFINION CX LEAD KIT

Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, i…

  • Totally Implanted For Pain Relief Spinal-Cord Stimulator
  • Device Design
Boston Scientific Neur…CAAug 12, 2026